These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
347 related articles for article (PubMed ID: 11723044)
21. PEDF inhibits VEGF- and EPO- induced angiogenesis in retinal endothelial cells through interruption of PI3K/Akt phosphorylation. Elayappan B; Ravinarayannan H; Pasha SP; Lee KJ; Gurunathan S Angiogenesis; 2009; 12(4):313-24. PubMed ID: 19657716 [TBL] [Abstract][Full Text] [Related]
22. Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy. Zhang SX; Wang JJ; Gao G; Parke K; Ma JX J Mol Endocrinol; 2006 Aug; 37(1):1-12. PubMed ID: 16901919 [TBL] [Abstract][Full Text] [Related]
23. PlGF silencing combined with PEDF overexpression: Modeling RPE secretion as potential therapy for retinal neovascularization. Araújo RS; Silva GA Mol Biol Rep; 2020 Jun; 47(6):4413-4425. PubMed ID: 32385771 [TBL] [Abstract][Full Text] [Related]
24. Modulation of thrombospondin 1 and pigment epithelium-derived factor levels in vitreous fluid of patients with diabetes. Wang S; Gottlieb JL; Sorenson CM; Sheibani N Arch Ophthalmol; 2009 Apr; 127(4):507-13. PubMed ID: 19365032 [TBL] [Abstract][Full Text] [Related]
25. High levels of pigment epithelium-derived factor in the retina of a rat model of type 2 diabetes. Matsuoka M; Ogata N; Minamino K; Higuchi A; Matsumura M Exp Eye Res; 2006 Jan; 82(1):172-8. PubMed ID: 16054135 [TBL] [Abstract][Full Text] [Related]
26. Ocular wounding prevents pre-retinal neovascularization and upregulates PEDF expression in the inner retina. Stitt AW; Graham D; Gardiner TA Mol Vis; 2004 Jun; 10():432-8. PubMed ID: 15235573 [TBL] [Abstract][Full Text] [Related]
27. Antiangiogenic effects and transcriptional regulation of pigment epithelium-derived factor in diabetic retinopathy. Wang B; Atherton P; Patel R; Manning G; Donnelly R Microvasc Res; 2010 Jul; 80(1):31-6. PubMed ID: 20219495 [TBL] [Abstract][Full Text] [Related]
28. Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization. Mori K; Duh E; Gehlbach P; Ando A; Takahashi K; Pearlman J; Mori K; Yang HS; Zack DJ; Ettyreddy D; Brough DE; Wei LL; Campochiaro PA J Cell Physiol; 2001 Aug; 188(2):253-63. PubMed ID: 11424092 [TBL] [Abstract][Full Text] [Related]
29. Overexpression of pigment epithelium-derived factor inhibits retinal inflammation and neovascularization. Park K; Jin J; Hu Y; Zhou K; Ma JX Am J Pathol; 2011 Feb; 178(2):688-98. PubMed ID: 21281801 [TBL] [Abstract][Full Text] [Related]
31. Pigment epithelium-derived factor acts as an opponent of growth-stimulatory factors in retinal glial-endothelial cell interactions. Yafai Y; Lange J; Wiedemann P; Reichenbach A; Eichler W Glia; 2007 Apr; 55(6):642-51. PubMed ID: 17309061 [TBL] [Abstract][Full Text] [Related]
32. Vitreous levels of proteins implicated in angiogenesis are modulated in patients with retinal or choroidal neovascularization. Huber M; Wachtlin J Ophthalmologica; 2012; 228(3):188-93. PubMed ID: 22868384 [TBL] [Abstract][Full Text] [Related]
33. Suppression of corneal neovascularization by PEDF release from human amniotic membranes. Shao C; Sima J; Zhang SX; Jin J; Reinach P; Wang Z; Ma JX Invest Ophthalmol Vis Sci; 2004 Jun; 45(6):1758-62. PubMed ID: 15161837 [TBL] [Abstract][Full Text] [Related]
34. [Pigment epithelium-derived factor and its application in retinal angiogenic diseases]. Liu H; Su GF Zhonghua Yan Ke Za Zhi; 2007 Nov; 43(11):1043-7. PubMed ID: 18307952 [TBL] [Abstract][Full Text] [Related]
35. Low content of the natural ocular anti-angiogenic agent pigment epithelium-derived factor (PEDF) in aqueous humor predicts progression of diabetic retinopathy. Boehm BO; Lang G; Volpert O; Jehle PM; Kurkhaus A; Rosinger S; Lang GK; Bouck N Diabetologia; 2003 Mar; 46(3):394-400. PubMed ID: 12687338 [TBL] [Abstract][Full Text] [Related]
36. Pigment epithelium-derived factor is a substrate for matrix metalloproteinase type 2 and type 9: implications for downregulation in hypoxia. Notari L; Miller A; Martínez A; Amaral J; Ju M; Robinson G; Smith LE; Becerra SP Invest Ophthalmol Vis Sci; 2005 Aug; 46(8):2736-47. PubMed ID: 16043845 [TBL] [Abstract][Full Text] [Related]
37. Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor. Stellmach V; Crawford SE; Zhou W; Bouck N Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2593-7. PubMed ID: 11226284 [TBL] [Abstract][Full Text] [Related]
38. Pigment epithelium-derived factor (PEDF) is an endogenous antiinflammatory factor. Zhang SX; Wang JJ; Gao G; Shao C; Mott R; Ma JX FASEB J; 2006 Feb; 20(2):323-5. PubMed ID: 16368716 [TBL] [Abstract][Full Text] [Related]
39. Growth factors/chemokines in diabetic vitreous and aqueous alter the function of bone marrow-derived progenitor (CD34⁺) cells in humans. Balaiya S; Grant MB; Priluck J; Chalam KV Am J Physiol Endocrinol Metab; 2014 Oct; 307(8):E695-702. PubMed ID: 25159325 [TBL] [Abstract][Full Text] [Related]
40. Polyethylene glycol-modified pigment epithelial-derived factor: new prospects for treatment of retinal neovascularization. Bai YJ; Huang LZ; Xu XL; Du W; Zhou AY; Yu WZ; Li XX J Pharmacol Exp Ther; 2012 Jul; 342(1):131-9. PubMed ID: 22495066 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]